Novavax, Inc. (NVAX): Price and Financial Metrics
NVAX Price/Volume Stats
| Current price | $7.32 | 52-week high | $23.86 |
| Prev. close | $7.22 | 52-week low | $3.53 |
| Day low | $6.81 | Volume | 9,347,900 |
| Day high | $7.33 | Avg. volume | 9,796,076 |
| 50-day MA | $11.26 | Dividend yield | N/A |
| 200-day MA | $10.03 | Market Cap | 1.17B |
NVAX Stock Price Chart Interactive Chart >
Novavax, Inc. (NVAX) Company Bio
Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.
NVAX Price Returns
| 1-mo | -29.28% |
| 3-mo | -43.52% |
| 6-mo | -50.51% |
| 1-year | 27.75% |
| 3-year | -96.02% |
| 5-year | 91.12% |
| YTD | 52.50% |
| 2023 | -53.31% |
| 2022 | -92.81% |
| 2021 | 28.30% |
| 2020 | 2,701.76% |
| 2019 | -89.18% |
Continue Researching NVAX
Want to see what other sources are saying about Novavax Inc's financials and stock price? Try the links below:Novavax Inc (NVAX) Stock Price | Nasdaq
Novavax Inc (NVAX) Stock Quote, History and News - Yahoo Finance
Novavax Inc (NVAX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...